BioSpace News Archive

Dompé farmaceutici announced new data revealing a novel function of the SARS-CoV-2 Spike protein interaction with the human Estrogen Receptor Alpha that may lead to the severe coagulopathy observed in patients with COVID-19 and a minority of subjects receiving the SARS-CoV-2 vaccine.

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has entered into a Partnership Agreement with Croda Pharma to build a robust, scalable and truly sustainable supply chain and deliver kilogram-quantities of QS-21 to the pharmaceutical industry.

The global cardiac resynchronization therapy market size was valued at USD 4.85 billion in 2020, and is predicted to be worth around USD 10.8 billion by 2030, registering a CAGR of 7.2% during the forecast period 2022 to 2030.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the US Food and Drug Administration has granted Orphan Drug Designation to OTOF-GT, Sensorion’s lead gene therapy program, intended for the treatment of otoferlin gene mediated hearing loss.

AGIC Capital, a growth-oriented private equity firm with $2.2 billion of assets under management, announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH.

A minimally invasive treatment for carpal tunnel syndrome provides complete and long-term relief to patients without the use of corticosteroids, according to research being presented at the annual meeting of the Radiological Society of North America.

Aurion Biotech today announced it has appointed Sherita Hall as vice president, clinical operations and Sterling Chung as vice president, global regulatory affairs.

Nimbus Therapeutics today announced positive topline results from a Phase 2b clinical trial evaluating the allosteric TYK2 inhibitor NDI-034858 in patients with moderate-to-severe plaque psoriasis.

Viseon Inc. Announces Preliminary Results of Surgeon Experience Database Utilizing MaxView ® System During Minimally Invasive Lateral Spine Surgery.

Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and outstanding shares (“Shares”) of Akouos’s common stock in exchange for (a) $12.50 per Share.